Biocryst Pharmaceuticals reported $115.6M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Chemocentryx CCXI:US $ 60.03M 4.65M
Chugai Pharma 4519:JP Y 244669M 38759M
Daiichi Sankyo 4568:JP Y 336046M 3275M
Enanta Pharmaceuticals ENTA:US $ 36.17M 7.55M
Gilead Sciences GILD:US $ 10245M 31M
GlaxoSmithKline GSK:LN 22417M 1030M
Glaxosmithkline GSK:US $ 22417M 1030M
Intra Cellular Therapies ITCI:US $ 49.9M 0.53M
IONIS PHARMACEUT IONS:US $ 218M 75.82M
Karyopharm Therapeutics KPTI:US $ 68.87M 10.74M
Mirati Therapeutics MRTX:US $ 122.08M 58.79M
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Novavax NVAX:US $ 1753.42M 101.9M
Ptc Therapeutics PTCT:US $ 465.26M 174.3M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Ultragenyx Pharmaceutical RARE:US $ 135.93M 8.87M
Vertex Pharmaceuticals VRTX:US $ 1914.26M 77.82M
YTE INCY:US $ 742.71M 82.39M
Zogenix ZGNX:US $ 78.43M 9.09M